Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Somatic tumor profiling of DNA mismatch repair deficient (MMR-D) colorectal cancers (CRC)
    Meeting Abstract

    Ganesh, K.; Middha, S.; Hechtman, J. F.; Ashraf, A.; Tran, C.; Villano, D.; Yaeger, R. D.; Segal, N. H.; Cercek, A.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Academic and Community Cancer Research United (ACCRU) RU011301I: Adjuvant ado-trastuzumab emtansine (T-DM1) for older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer
    Meeting Abstract

    Freedman, R. A.; Polley, M. Y.; Dueck, A. C.; Hurria, A.; Muss, H. B.; Ruddy, K. J.; Hubbard, J. M.; Liu, H.; Rogak, L. J.; Basch, E. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Accrual of older patients (pts) with breast cancer to Alliance systemic therapy trials over time: A151527
    Meeting Abstract

    Freedman, R. A.; Seisler, D. K.; Foster, J. C.; Lafky, J. M.; Kimmick, G. G.; Jatoi, A.; Muss, H. B.; Cohen, H. J.; Mandelblatt, J. S.; Winer, E. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
    Meeting Abstract

    Chakravarty, D.; Phillips, S. M.; Gao, J.; Kundra, R.; Zhang, H.; Rudolph, J. E.; Yaeger, R. D.; Soumerai, T.; Nissan, M. H.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical characterization of DNA mismatch repair deficiency (MMR-D) in endometrial cancer (EC)
    Meeting Abstract

    Cadoo, K. A.; Tran, C.; DeLair, D.; Arnold, A. G.; Ashraf, A.; Jewell, E. L.; Kauff, N. D.; Long, K.; Mueller, J. J.; Robson, M. E.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlates of work status during adjuvant chemo- or radiation therapy for breast cancer
    Meeting Abstract

    Blinder, V. S.; Eberle, C. E.; Patil, S.; Oeffinger, K. C.; Bradley, C.; Gany, F.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Interim joint analysis of the ABC (anthracyclines in early breast cancer) phase III trials (USOR 06-090, NSABP B-46I/USOR 07132, NSABP B-49 [NRG Oncology]) comparing docetaxel plus cyclophosphamide (TC) v anthracycline/taxane-based chemotherapy regimens (TaxAC) in women with high-risk, HER2-negative breast cancer
    Meeting Abstract

    Blum, J. L.; Flynn, P. J.; Yothers, G.; Asrnar, L.; Geyer, C. E.; Jacobs, S. A.; Robert, N. J.; Atkins, J. N.; O'Shaughnessy, J.; Dang, C. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of genetic test results with conflicting interpretations in prospective registry of multiplex testing (PROMPT)
    Meeting Abstract

    Balmana, J.; Digiovanni, L.; Gaddam, P.; Walsh, M. F.; Garber, J. E.; Couch, F. J.; Offit, K.; Robson, M. E.; Domchek, S. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase (Ph) 1 study of oral seviteronel (VT-464), a dual CYP17-Lyase (L) inhibitor and androgen receptor (AR) antagonist, in patients (pts) with advanced AR plus triple negative (TNBC) or estrogen receptor (ER) plus breast cancer (BC)
    Meeting Abstract

    Bardia, A.; Dacosta, N. A.; Gabrail, N. Y.; Lemon, S.; Danso, M. A.; Ali, H. Y.; Fleming, R. A.; Kurman, M. R.; Eisner, J. R.; Moore, W. R.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Prevalence, risk factors, and sequelae of long-term chemotherapy-induced peripheral neuropathy (CIPN) among breast cancer survivors
    Meeting Abstract

    Bao, T.; Li, S. Q.; Mao, J. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save